[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Fri, Apr 24th, 2026

The Ultimate List of Cannabis ETFs

A list of publicly traded cannabis, marijuana, and 420 friendly stocks and ETFs.
Fri, Apr 24th, 2026

The legal cannabis market continues to expand across the globe, and the names on this page offer exposure to the rapidly evolving industry. Cannabis stocks can include companies involved in every stage of the production and marketing process - from greenhouse cultivation to retail dispensaries, plus ancillary services like lighting equipment and fertilizer. While there’s still heightened volatility and regulatory risk involved in trading cannabis stocks, this list highlights the best growth opportunities in this burgeoning space right now.

To learn more about the cannabis industry and which stocks could be poised for greatness, please watch our webinar.

View Profiles of these companies to see how they are involved in the cannabis / marijuana industry.

Cannabis News

Reclassifying marijuana as a less dangerous drug might only be the first step for Trump

President Donald Trump’s decision to reclassify state-licensed medical marijuana as a less dangerous drug is a boon for the industry

What to know about a federal order reclassifying medical marijuana as a less dangerous drug

President Donald Trump's administration has reclassified medical marijuana as a less dangerous drug

Trump reclassifies state-licensed medical marijuana as a less-dangerous drug in a historic shift

A cannabis industry group calls President Donald Trump’s reclassification of state-licensed medical marijuana as a less-dangerous drug “the most significant federal advancement in cannabis policy"...

Trump's acting attorney general reclassifies state-licensed medical marijuana as a less-dangerous drug in a major shift

Trump's acting attorney general reclassifies state-licensed medical marijuana as a less-dangerous drug in a major shift

Jazz Pharmaceuticals Stock, a Barchart Favorite, Trends Higher as Trump Renews Cannabis Hopes. Should You Buy JAZZ Here?

Jazz Pharmaceuticals stock pops as President Trump signals renewed urgency to reclassify cannabis as Schedule III drug. Technicals signal further upside ahead in JAZZ shares.

JAZZ : 197.47 (-1.25%)
Tilray Stock Pops on New Trump-Driven Cannabis Hopes. Should You Chase the Rally?

Tilray shares rally as Trump urges the DOJ to quickly reclassify cannabis as a Schedule III drug. Options pricing suggests TLRY stock could rip higher through mid-September.

TLRY : 6.76 (-2.59%)
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.